Below are the most recent publications written about "Membrane Proteins" by people in Profiles.
-
Birnbaum EM, Xie L, Serrano P, Rockwell P, Figueiredo-Pereira ME. BT-11 targets the LANCL2 pathway to attenuate cognitive deficits and hippocampal pathology in Alzheimer's transgenic rats. Sci Rep. 2025 Dec 23; 16(1):1848.
-
Singh S, Weindorfer C, Nandi A, Panneer Selvam C, Mendes G?tze M, Das M, Falaschini A, Tjendra Y, Boone MM, Dolznig H, Zhang Q, Clarke R, Thomas C, Chakrabarti R. DLL1-responsive PD-L1+ tumor-associated macrophages promote endocrine resistance in breast cancer. Sci Transl Med. 2025 Nov 05; 17(823):eadr6207.
-
Morales-Cab?n BM, Cantres-Rosario YM, Tosado-Rodr?guez EL, Roche-Lima A, Mel?ndez LM, Boukli NM, Suarez-Arroyo IJ. SCAMP3-Driven Regulation of ERK1/2 and Autophagy Phosphoproteomics Signatures in Triple-Negative Breast Cancer. Int J Mol Sci. 2025 Oct 01; 26(19).
-
Okafor EO, Bella-Omunagbe M, Elugbadebo T, Dokunmu TM, Adebiyi E. Targeting invasion-associated proteins PfSUB2 and PfTRAMP in Plasmodium falciparum: identification of potential inhibitors via molecular docking. BMC Infect Dis. 2025 Aug 19; 25(1):1038.
-
Soni S, Yildiz S, Allen EK, Petersen H, Peeples M, El Zahed S, Rosas L, Anang V, Antonescu L, Nho RS, Mora AL, Horowitz JC, Rojas M, Medina RA, Thomas PG, Garc?a-Sastre A, Tesfaigzi Y, Mebratu YA. BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza. Proc Natl Acad Sci U S A. 2025 Jul 15; 122(28):e2424367122.
-
Nelson KL, Reil KA, Tsuji S, Parikh AM, Robinson M, House CD, McGuire KL, Giacalone MJ. VAX014 Activates Tumor-Intrinsic STING and RIG-I to Promote the Development of Antitumor Immunity. Mol Cancer Ther. 2025 Apr 02; 24(4):587-604.
-
Villarreal-Garc?a V, Estupi?an-Jim?nez JR, Gonzalez-Villasana V, Vivas-Mej?a PE, Flores-Col?n M, Ancira-Moreno IE, Zapata-Mor?n PA, Altamirano-Torres C, V?zquez-Guillen JM, Rodr?guez-Padilla C, Bayraktar R, Rashed MH, Ivan C, Lopez-Berestein G, Res?ndez-P?rez D. Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. 2024 Dec 21; 161(1):53.
-
Stiff A, Fornerod M, Kain BN, Nicolet D, Kelly BJ, Miller KE, Mr?zek K, Boateng I, Bollas A, Garfinkle EAR, Momoh O, Fasola FA, Olawumi HO, Mencia-Trinchant N, Kloppers JF, van Marle AC, Hu E, Wijeratne S, Wheeler G, Walker CJ, Buss J, Heyrosa A, Desai H, Laganson A, Hamp E, Abu-Shihab Y, Abaza H, Kronen P, Sen S, Johnstone ME, Quinn K, Wronowski B, Hertlein E, Miles LA, Mims AS, Oakes CC, Blachly JS, Larkin KT, Mundy-Bosse B, Carroll AJ, Powell BL, Kolitz JE, Stone RM, Duarte C, Abbott D, Amaya ML, Jordan CT, Uy GL, Stock W, Archer KJ, Paskett ED, Guzman ML, Levine RL, Menghrajani K, Chakravarty D, Berger MF, Bottomly D, McWeeney SK, Tyner JW, Byrd JC, Salomonis N, Grimes HL, Mardis ER, Eisfeld AK. Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia. Nat Genet. 2024 Nov; 56(11):2434-2446.
-
Farris T, Gonz?lez-Ochoa S, Mohammed M, Rajakaruna H, Tonello J, Kanagasabai T, Korolkova O, Shimamoto A, Ivanova A, Shanker A. Loss of Mitochondrial Tusc2/Fus1 Triggers a Brain Pro-Inflammatory Microenvironment and Early Spatial Memory Impairment. Int J Mol Sci. 2024 Jul 05; 25(13).
-
Adang LA, D'Aiello R, Takanohashi A, Woidill S, Gavazzi F, Behrens EM, Sullivan KE, Goldbach-Mansky R, de Jesus AA, Vanderver A, Shults J. IFN-signaling gene expression as a diagnostic biomarker for monogenic interferonopathies. JCI Insight. 2024 Jun 17; 9(14).